Company Profile

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE355.8022.7 (+6.81 % )
PREV CLOSE (Rs.) 333.10
OPEN PRICE (Rs.) 336.00
BID PRICE (QTY) 355.80 (900 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 5669
TODAY'S LOW / HIGH (Rs.)336.00 363.00
52 WK LOW / HIGH (Rs.)304.75 612.9
NSE360.30 25.35 (+7.57 % )
PREV CLOSE(Rs.) 334.95
OPEN PRICE (Rs.) 331.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 360.30 (69 )
VOLUME 63816
TODAY'S LOW / HIGH(Rs.) 331.00 366.00
52 WK LOW / HIGH (Rs.)296.05 613

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.56
TTM EPS (Rs.) 17.11
P/E Ratio 20.79
Book Value (Rs.) 51.69
Face Value (Rs.) 2
MCap (Rs. in Mn) 26909.24
Price/Earning (TTM) 17.67
Price/Sales (TTM) 5.31
Price/Book (MRQ) 6.88
PAT Margin (%) 23.98
ROCE (%) 58.99
Incorporation Year : 1990

Management Info :

C C Paarthipan - Chairman Sridhar Ganesan - Managing Director

Registered Office :

Address : Narbavi, No . 3,Lakshmanan Street ,T Nagar ,
Chennai,
Tamil Nadu-600017

Phone : 91-044-28156653 / 28156905

Registrar's Details : Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai
NEWS More
11Apr04-11-2019$ Announcement under Regulation 30 (LODR)-Cessation Announcement under Regulati
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015, we wish to inform BSE that Dr Philip Ashok Karunakaran has tendered his resignation from the position of Whole-time Director and from the Board due to health reasons, effective from the close of business working hours on April 10, 2019. The Company wishes to place on record the valuable contributions made by Dr Philip Ashok Karunakaran during his tenure as a Whole-time Director. We further wish to inform that the Company has appointed Mr M Panjatcharam (who was previously the Head of R&D - Quality at Sun Pharmaceuticals Industries Limited) as a Whole-time Director of Caplin Steriles Limited (Wholly Owned Subsidiary Company) and as Head of Quality, R&D and Operations for the Company's regulated markets injectable business, including US FDA approved injectable plant and DSIR recognised R&D Units CP4 & CP 5, which is now Caplin Steriles Limited. Mr. Panjatcharam is an Analytical Chemistry Post Graduate and a Pharma Professional with more than 25 years of experience in various Quality Control, Assurance and R&D Functions in API, Formulation, Pharma R&D, Biologics with Strong Exposure on cGMP Requirements & Designing of Product Quality Attributes on Injectables, Ophthalmics, Inhalers, Oncology Products, Potent Molecules and Peptides. He was Involved in many successful regulated inspections of USFDA, EUGMP, MHRA, MCC, TGA, ANVISA and BFRM. His past assignments include Quality leadership roles in Dr.Reddy's Laboratories Limited, Dabur Research Foundation, Aurobindo Pharma Limited etc.
Pursuant to Regulation 30 of SEBI (Listing Obligations and D..
13Feb02-13-2019$ Announcement under Regulation 30 (LODR)-Allotment Announcement under Regulati
ALLOTMENT OF EQUITY SHARES UNDER EMPLOYEE STOCK OPTION PLAN-2015.
ALLOTMENT OF EQUITY SHARES UNDER EMPLOYEE STOCK OPTION PLAN-2015.
13Feb02-13-2019$ Loss of Share Certificate / Issue of Duplicate Share Certificate Loss of Share Certificate /
Caplin Point Laboratories Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate.
Caplin Point Laboratories Ltd has informed BSE regarding Loss o..
Financials More
Rs. in Millions
QTR Dec 18 ANNUAL 18
Net Profit368.591023.11
Gross Profit 508.61 1460.53
Operating Profit 565.421651.02
Net Sales 1397.624265.74
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Abbott India (BSE)
 7392.30 (2.83%)
M.Cap ( in Cr)
15708.12
Procter&Gamble Healt (BSE)
 4342.55 (3.17%)
M.Cap ( in Cr)
7208.36
Astrazeneca Pharma I (BSE)
 2343.00 (4.79%)
M.Cap ( in Cr)
5857.50
Piramal Enterprises (BSE)
 2133.40 (4.28%)
M.Cap ( in Cr)
42380.15
Pfizer (BSE)
 3003.70 (0.76%)
M.Cap ( in Cr)
13741.25
Shareholding Pattern More
PROMOTERS 69.04 %
NON-INSTITUTION 23.63 %
FI/BANKS/INSURANCE 0.02 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
ICICI Pru S&P BSE 500 ETF0.01
F & O Quotes

Open A

New Account

Name
Email
Mobile Number
City
Select Products You Are Interested